Education
About Us
Working with TipRanks
Follow Us
Immuno-Biological Laboratories Co., Ltd. (JP:4570)
:4570
RESEARCH TOOLSreports
4570 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥356.00 - ¥603.00
Previous CloseN/A
Volume75.00K
Average Volume (3M)82.86K
Market Cap
¥5.08B
Enterprise ValueN/A
Total Cash (Recent Filing)¥753.00M
Total Debt (Recent Filing)¥190.00M
Price to Earnings (P/E)20.4
Beta0.66
Next Earnings
Aug 01, 2025EPS EstimateN/A
Last Dividend Ex-Date
Mar 27, 2013Dividend YieldN/A
Share Statistics
EPS (TTM)12.42
Shares Outstanding9,314,590
10 Day Avg. Volume102,060
30 Day Avg. Volume82,860
Financial Highlights & Ratios
PEG Ratio0.53
Price to Book (P/B)3.36
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
4570 FAQ
What was Immuno-Biological Laboratories Co., Ltd.’s price range in the past 12 months?
Immuno-Biological Laboratories Co., Ltd. lowest stock price was ¥356.00 and its highest was ¥603.00 in the past 12 months.
What is Immuno-Biological Laboratories Co., Ltd.’s market cap?
Immuno-Biological Laboratories Co., Ltd.’s market cap is ¥5.08B.
When is Immuno-Biological Laboratories Co., Ltd.’s upcoming earnings report date?
Immuno-Biological Laboratories Co., Ltd.’s upcoming earnings report date is Aug 01, 2025 which is in 60 days.
How were Immuno-Biological Laboratories Co., Ltd.’s earnings last quarter?
Immuno-Biological Laboratories Co., Ltd. released its earnings results on May 14, 2025. The company reported ¥12.42 earnings per share for the quarter, beating the consensus estimate of N/A by ¥12.42.
Is Immuno-Biological Laboratories Co., Ltd. overvalued?
According to Wall Street analysts Immuno-Biological Laboratories Co., Ltd.’s price is currently Overvalued.
Does Immuno-Biological Laboratories Co., Ltd. pay dividends?
Immuno-Biological Laboratories Co., Ltd. pays a Notavailable dividend of ¥5 which represents an annual dividend yield of N/A. See more information on Immuno-Biological Laboratories Co., Ltd. dividends here
What is Immuno-Biological Laboratories Co., Ltd.’s EPS estimate?
Immuno-Biological Laboratories Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Immuno-Biological Laboratories Co., Ltd. have?
Immuno-Biological Laboratories Co., Ltd. has 9,314,590 shares outstanding.
What happened to Immuno-Biological Laboratories Co., Ltd.’s price movement after its last earnings report?
Immuno-Biological Laboratories Co., Ltd. reported an EPS of ¥12.42 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.702%.
Which hedge fund is a major shareholder of Immuno-Biological Laboratories Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4570
Company Description
Immuno-Biological Laboratories Co., Ltd.
Immuno-Biological Laboratories Co., Ltd. (4570) is a Japanese company specialized in the development, manufacturing, and distribution of diagnostic reagents and research kits. The company primarily operates within the healthcare sector, focusing on providing products that aid in the diagnosis and research of various diseases. Their offerings include a wide range of immunological and biochemical products that cater to medical professionals and research institutions.
Technical Analysis
Ribomic, Inc.
―
BrightPath Biotherapeutics Co.Ltd.
―
Delta-Fly Pharma, Inc.
―
FunPep Company Limited
―
Kringle Pharma, Inc.
―